Exabis Library
Welcome to the e-CCO Library!
OP16: Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologics
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP16: Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn’s disease by number and type of prior biologics
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP16: The first virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic remission in Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP17 Protein intakes and risk of inflammatory bowel disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP17: A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsies
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP17: A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsies
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP17: IBD ulcers are characterized by bioactive interleukin-1 and transcriptomic hallmarks of stromal cell state reprogramming
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
OP17: Impact of phenotypic and genetic factors on Crohn’s Disease evolution in a cohort of 13,926 patients
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP17: Impact of phenotypic and genetic factors on Crohn’s Disease evolution in a cohort of 13,926 patients
2021
ECCO'21 Virtual
Friday, 1 October 2021, 12:41 PM
OP17: Maintenance phase propensity score adjusted effectiveness and persistence at week-52 in biologic-naïve Ulcerative Colitis patients treated with vedolizumab or anti-TNF (VEDO IBD-study)
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP17: Protein intakes and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD).
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
OP17: Protein intakes and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD).
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP17: Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn's Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP17: Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn’s Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP18 Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn’s disease: The SuPREMe-CD study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP18: Disease course of Crohn's disease during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP18: Disease course of Crohn’s disease during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP18: Efficacy and safety of darvadstrocel treatment in patients with complex perianal fistulas and Crohn’s Disease: results from the global ADMIRE-CD II phase 3 study
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
OP18: Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn’s Disease: Results from the phase 2 DIVERGENCE 2 study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP18: Proactive adalimumab trough measurements increase corticosteroid-free clinical remission in paediatric patients with Crohn’s disease: the paediatric Crohn’s disease adalimumab-level-based optimisation treatment (PAILOT) trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM